Insider Trading & Ownership of BROADWOOD PARTNERS, L.P.

Location
New York, NY
Summary
The estimated value of insider holdings of BROADWOOD PARTNERS, L.P. is at least $933,310,322 dollars as of 12 Feb 2026. BROADWOOD PARTNERS, L.P. is the 10%+ Owner of STAAR SURGICAL CO and owns shares of STAAR SURGICAL CO (STAA) stock worth about $697.63M. BROADWOOD PARTNERS, L.P. is the 10%+ Owner of Insight Molecular Diagnostics Inc. and owns shares of Insight Molecular Diagnostics Inc. (IMDX) stock worth about $160.35M. BROADWOOD PARTNERS, L.P. is the Director, 10%+ Owner of Lineage Cell Therapeutics, Inc. and owns shares of Lineage Cell Therapeutics, Inc. (LCTX) stock worth about $75.33M.
Signature
Broadwood Partners, L.P., By Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President
All Insider Reports
All Insider Reports

Notify me when BROADWOOD PARTNERS, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of BROADWOOD PARTNERS, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STAA STAAR SURGICAL CO 10%+ Owner $697,629,354 +$75,904,166 +12% 09 Jan 2026
IMDX Insight Molecular Diagnostics Inc. 10%+ Owner $160,348,260 +$2,999,999 +1.9% 10 Feb 2026
LCTX Lineage Cell Therapeutics, Inc. Director, 10%+ Owner $75,332,708 27 Jan 2025

Insider Transactions Reported by BROADWOOD PARTNERS, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.